Scheme Rating
PMS Scheme Ratings are driven by IME’s Proprietary Scheme Rating Methodology, which takes into account our ratings of the Scheme’s investment strategy, its maturity, the investment team, and our separate rating on the AMC that runs this particular scheme. Our views on each of these individual criteria are available via the IME RMS – which you can view by reaching out to one of our relationship managers (using either the live chat or book appointment feature on this site).
Investment Philosophy
The aim is to invest in high-conviction growth businesses that have a sustainable competitive advantage and are run by clean and competent management at reasonable valuations. The focus is on investing in superior businesses, and SageOne will not invest in a weak business irrespective of how attractive the valuations may appear.
Investment Philosophy Built On
- Superior Growth: minimum 20% compounded earnings growth at individual level and 25% at portfolio level
- Market Share Gains: to contribute to incremental growth in earnings
- Profitability: strong and profitable businesses with >20% ROEs to fund growth internally
- Capital Allocation: incremental ROE higher than existing ROEs
- Efficient Moat: most efficient players industries (leaders or expected leaders due to superior strategy and positioning)
- Reasonable Valuation: SageOne will not invest in a weak business irrespective of how attractive the valuations may appear.
RISK MANAGEMENT
- Prudent Stock Selection: driven by financial and business analysis, internal forensic model to eliminate questionable business practices and management, and portfolio construction to minimise non-systemic risk
- Sectoral and Stock Limits: Maximum 25% exposure to a sector and maximum 20% exposure to any business group
- Timely Rebalancing: Active calls on liquidity based on external risk factors (macro, market volatility and valuations)
- Active Monitoring and Action: Strong network across industries for channel checks. Active entry/exit on changing business dynamics.
Trailing Performance
| 1yr | 3yr | 5yr | Since Inception | |
|---|---|---|---|---|
| SageOne Mid & Small Cap | 15.9 | 16.1 | 24.7 | 18.3 |
| S&P BSE 500 | 8.4 | 12.7 | 16.8 | 16 |
| Alpha over Broad Mkt BM | 7.5 | 3.4 | 7.9 | 2.3 |
| Nifty Midcap 150 | 11 | 20.3 | 24.4 | |
| Alpha over Category BM | 4.9 | -4.2 | 0.3 |
Performance as of: 31-Jan-25 | Inception Date: 22-Jan-17
Fund Managers
Samit Vartak | 4-star rated FM
Founder & CIO | 26 yrs Experience | 13 yrs at current firm
Past Experience: Axis PE (VP), Ernst & Young (Associate Director)
Samit is the Founding Partner & CIO of SageOne. He has experience in Private Equity (at Axis PE Fund) and Corporate Strategy, Investment Banking and Business Valuations in the US (at E&Y and Deloitte).
Fee Structure
| Fee Structure | Fee |
|---|---|
| Fixed Fee Structure | 2.5 |
| Variable Fee Structures | 1.25% fixed + 12% above 10% hurdle |
| Exit Fees | 1yr(3%), 2yr(2%), 3yr(1%) |
Free 30-Day Trial of the IME RMS
Details shared above, are only a short-snapshot of the more detailed analysis that resides in IME’s Proprietary RMS (Research Management Solution).
The IME RMS is the first tool ever, to give investors direct access to the insights of the central research team. Investors gain direct access to our ratings, rating rationales & analysis across thousands of funds (MFs, PMSs, AIFs, Global funds), asset classes, categories & more.
Note: PMS AMC & Scheme Reviews and Ratings are based on IME Capital’s Proprietary Review and Rating Methodology (read more here: AMC Rating & Scheme Ratings). These reflect the unbiased views of our central research team, based on our assessment of the investment value of these PMS/AIF strategies for our investors. We follow a highly stringent rating-criteria, where approximately 50% of PMS AMC’s & strategies would be rated 2-star or below (this is not meant to indicate that these funds are not investment-worthy, but that they do not currently fulfill the requirements we focus on for recommending funds to our investors — based on our internal views on the merit of the AMC/strategy relative to peers). Reviews & Ratings are primarily based on research of publicly available information (SEBI disclosures, PMS websites, PMS-aggregation platforms, webinar recording, media interviews etc.) and no explicit consent is required from AMCs for the same. While we endeavour to do further due-diligence via direct interactions with the investment teams of AMCs, this is typically restricted to AMC’s that meet our foundational fund selection criteria (reviews on lower-rated AMCs are often based solely on publicly available information). The views reflected in our Reviews & Ratings, are our independent views and may not be shared by the AMC’s and the investment teams. Please read detailed disclaimer for more.